Detalhe da pesquisa
1.
Clinical performance study of a fecal bacterial signature test for colorectal cancer screening.
PLoS One
; 18(11): e0293678, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37992030
2.
A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples.
Front Microbiol
; 12: 639948, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33833742
3.
RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment.
Inflamm Bowel Dis
; 27(Suppl 2): S63-S66, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791288
4.
In vitro Prebiotic Effect of Bread-Making Process in Inflammatory Bowel Disease Microbiome.
Front Microbiol
; 12: 716307, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34707578
5.
New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
PLoS One
; 15(12): e0243158, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259546
6.
Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers.
Aliment Pharmacol Ther
; 49(11): 1410-1420, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025420